Trial site
Providence Cancer Institute
- 15running trials
- 7closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Lung cancer12 trials
- Head and neck cancer7 trials
- Colorectal cancer6 trials
- Melanoma6 trials
- Ovarian cancer6 trials
- Bladder cancer5 trials
- Gastric and oesophageal cancer5 trials
- Kidney cancer4 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Liver and biliary tract cancer2 trials
- Brain metastases1 trial
- and 5 more
- Phase
- Phase 19 trials
- Phase 1/26 trials
- Phase 25 trials
- Phase 32 trials
- Status
- Recruiting10 trials
- Active, not recruiting5 trials
- Completed4 trials
- Terminated3 trials
- Lead sponsor
- Imunon2 trials
- Agenus Inc.1 trial
- Ankyra Therapeutics, Inc1 trial
- Boehringer Ingelheim1 trial
- Celldex Therapeutics1 trial
- and 16 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Recruiting
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Recruiting
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Active, not recruiting
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Colorectal cancer3 recruiting
- Ovarian cancer3 recruiting
- Bladder cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Prostate cancer2 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Terminated
HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer
Completed
Terminated
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
Completed
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
Completed
Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026